Table 1 |
|||||
|
Statistics of multivariate analysis models demonstrating an association between 1H NMR spectroscopic data and several biological and lifestyle factors. |
|||||
|
Model Description |
Y variable |
Number of LVs |
R2X |
Q2Y |
Significance (P value) |
|
|
|||||
|
A. PLS |
ln(U-Cd) |
3 |
0.251 |
0.237 |
< 0.01 |
|
B. PLS (current smokers excluded) |
ln(U-Cd) |
5 |
0.308 |
0.330 |
< 0.001 |
|
C. PLS (past and current smokers excluded) |
ln(U-Cd) |
1 |
0.0729 |
0.142 |
< 0.001 |
|
D. PLS |
sex |
3 |
0.241 |
0.104 |
> 0.05 |
|
E. PLS |
age |
2 |
0.216 |
0.224 |
< 0.001 |
|
F. PLS |
ln(U-NAG) |
1 |
0.054 |
0.162 |
< 0.001 |
|
G. PLS-DA |
Smoking historya |
2 |
0.194 |
0.185 |
< 0.01 |
|
|
|||||
|
aSmoking history was defined as either 1 = never smoked and past smoker (n = 106) or 2 = current smoker (n = 20), one individual did not complete the lifestyle questionnaire. Spectra that exhibited signs of bacterial contamination, analgesics or ethanol were excluded from these analyses. All variables were mean-centred and scaled to unit variance. NMR data were reduced to 1,127 data points of δ 0.01 resolution. Sample numbers for PLS models: A, D, E and F: n = 127. B: n = 106. C: n = 79. PLS-DA (model G) n = 126. Number of latent variables in a model were auto-fitted in SIMCA-P+. All models were assessed for validity by Y variable permutation analysis (1,000 permutations, see additional file 1 Figure S4). Scores scatter plots for each multivariate model can also be found in additional file 1 (Figure S5). ln(U-Cd), natural logarithm of urinary cadmium; ln(U-NAG), natural logarithm of urinary-N-acetyl-β-D-glucosaminidase; LV, latent variable; n, sample number; PLS, partial least squares; PLS-DA, partial least squares - discriminant analysis. R2X is the proportion of variance in the X matrix (i.e. spectral NMR data) described by the PLS model. Q2Y is the ability of the PLS model to predict the Y-score (ln(U-Cd), sex, age, ln(U-NAG) or smoking status) of a novel sample or the "cross-validated goodness-of-fit". |
|||||
|
Ellis et al. BMC Medicine 2012 10:61 doi:10.1186/1741-7015-10-61 |
|||||